CYCLE CHARACTERISTICS AND OUTCOME IN RELATION TO OVARIAN RESPONSE DURING IN-VITRO FERTILIZATION

被引:8
作者
FLUKER, MR
SIU, CK
GUNBY, J
DAYA, S
机构
[1] In Vitro Fertilization Program, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, V6H 3V5, British Columbia, Grace Hospital-Room 2H30
[2] Obstetrics and Gynecology Unit, Queen Elizabeth Hospital, Kowloon, Hong Kong
[3] Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario
关键词
EMBRYO QUALITY; IN-VITRO FERTILIZATION; OOCYTE QUALITY; OVARIAN STIMULATION;
D O I
10.1007/BF01204360
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: This retrospective analysis of 148 non-male factor couples sought to determine whether oocyte or embryonic quality was compromised by the magnitude of the ovarian response following clomiphene citrate/human menopausal gonadotropin stimulation for in vitro fertilization. Methods: Increased oocyte numbers were associated with decreased fertilization rates (r = -0.36, P < 0.001) and estradiol/follicle ratios (r = -0.443, P < 0.001), although the quality of the resulting embryos was not affected. Despite reduced fertilization, higher oocyte numbers yielded additional healthy embryos (r = 0.70, P < 0.001) for immediate replacement or cryopreservation. Implantation rates did not differ among groups and no predictive variables were identified. Results: These results suggest that endometrial receptivity and implantation were not adversely affected by increasing estradiol levels. The decline in oocyte quality associated with the retrieval of larger numbers of oocytes appeared to be offset by the availability of additional embryos for immediate replacement and cryopreservation.
引用
收藏
页码:504 / 512
页数:9
相关论文
共 22 条
[1]  
Hughes E.G., King C., Wood E.C., A prospective study of prognostic factors in in vitro fertilization and embryo transfer, Fertil Steril, 51, pp. 838-844, (1978)
[2]  
Pellicer A., Ruiz A., Castellvi R.M., Calatayud C., Ruiz M., Tarin J.J., Miro F., Bonilla-Musoles F., Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins?, Hum Reprod, 4, pp. 536-540, (1989)
[3]  
Diamond M.P., Buchholz T., Boyers S.P., Lavy G., Shapiro B.S., DeCherney A.H., Super high estradiol response to gonadotropin stimulation in patients undergoing in vitro fertilization, J Vitro Fert Embryo Transfer, 6, pp. 81-84, (1989)
[4]  
Chenette P.E., Sauer M.V., Paulson R.J., Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization, Fertil Steril, 54, pp. 858-863, (1990)
[5]  
Testart J., Belaisch-Allart J., Forman R., Gazengel A., Strubb N., Hazout A., Frydman R., Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability, Hum Reprod, 4, pp. 192-197, (1989)
[6]  
Sharma V., Riddle A., Mason B.A., Pampiglione J., Campbell S., An analysis of factors influencing the establishment of a clinical pregnancy in an ultrasound-based ambulatory in vitro fertilization program, Fertil Steril, 49, pp. 468-478, (1988)
[7]  
WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Interaction, (1987)
[8]  
Ho Yuen B., Pride S.M., Rowe T.C., Moon Y.S., McComb P.F., Poland B.J., Gomel V., Comparison of the outcome of ovulation induction therapy in an in vitro fertilization program employing low-dose and an individually adjusted high-dose schedule of human menopausal gonadotropins, Am J Obstet Gynecol, 151, pp. 172-175, (1985)
[9]  
Pride S., James C., Ho Yuen B., The ovarian hyperstimulation syndrome, Semin Reprod Endocrinol, 8, pp. 247-260, (1990)
[10]  
Veeck L.L., Wortham J.W.E., Witmeyer J., Sandow B.A., Acosta A.A., Garcia J.E., Et al., Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization, Fertil Steril, 39, pp. 594-602, (1983)